Effects of propofol-based total intravenous anesthesia on recurrence and overall survival in patients after modified radical mastectomy: A retrospective study

Korean Journal of Anesthesiology

Volumn 69, Issue 2, 2016, Pages 126-132

  Lee, Ji Heui ^a   Kang, Seok Hee ^a   Kim, Yunkwang ^a   Kim, Hyun Ah ^a   Kim, Bong Seog ^b  

^a Korea Cancer Center Hospital   (South Korea)

^b Veterans Health Service Medical Center   (South Korea)

Author keywords

Breast neoplasms; Propofol; Recurrence; Sevoflurane

Indexed keywords

ALFENTANIL; DICLOFENAC; FENTANYL; GLYCOPYRRONIUM BROMIDE; KETOROLAC; MIDAZOLAM; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PETHIDINE; PROPOFOL; REMIFENTANIL; ROCURONIUM; SEVOFLURANE; THIOPENTAL;

ADULT; ARTICLE; BISPECTRAL INDEX; BREAST CANCER; CANCER PROGNOSIS; ENDOTRACHEAL INTUBATION; GENERAL ANESTHESIA; HEMODYNAMIC MONITORING; HUMAN; INTRAVENOUS ANESTHESIA; MAJOR CLINICAL STUDY; MASTECTOMY; MIDDLE AGED; MODIFIED RADICAL MASTECTOMY; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; PROPOFOL BASED TOTAL INTRAVENOUS ANESTHESIA; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; RETROSPECTIVE STUDY; RISK FACTOR; SEVOFLURANE BASED ANESTHESIA;

EID: 84962724841     PISSN: 20056419     EISSN: 20057563     Source Type: Journal    
DOI: 10.4097/kjae.2016.69.2.126     Document Type: Article

References (30)

1. Demicheli R, Retsky MW, Hrushesky WJ, Baum M, Gukas ID. The effects of surgery on tumor growth: a century of investigations. Ann Oncol 2008; 19: 1821-8.
2. Tsuchiya Y, Sawada S, Yoshioka I, Ohashi Y, Matsuo M, Harimaya Y, et al. Increased surgical stress promotes tumor metastasis. Surgery 2003; 133: 547-55.
3. Melamed R, Bar-Yosef S, Shakhar G, Shakhar K, Ben-Eliyahu S. Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures. Anesth Analg 2003; 97: 1331-9.
4. Lysle DT, Coussons ME, Watts VJ, Bennett EH, Dykstra LA. Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone. J Pharmacol Exp Ther 1993; 265: 1071-8.
5. Page GG, Blakely WP, Ben-Eliyahu S. Evidence that postoperative pain is a mediator of the tumor-promoting effects of surgery in rats. Pain 2001; 90: 191-9.
6. Snyder GL, Greenberg S. Effect of anesthetic technique and other perioperative factors on cancer recurrence. Br J Anaesth 2010; 105: 106-15.
7. Ecimovic P, Murray D, Doran P, Buggy DJ. Propofol and bupivacaine in breast cancer cell function in vitro-role of the NET1 gene. Anticancer Res 2014; 34: 1321-31.
8. Juneja R. Opioids and cancer recurrence. Curr Opin Support Palliat Care 2014; 8: 91-101.
9. Shavit Y, Ben-Eliyahu S, Zeidel A, Beilin B. Effects of fentanyl on natural killer cell activity and on resistance to tumor metastasis in rats. Dose and timing study. Neuroimmunomodulation 2004; 11: 255-60.
10. Sacerdote P, Gaspani L, Rossoni G, Panerai AE, Bianchi M. Effect of the opioid remifentanil on cellular immune response in the rat. Int Immunopharmocol 2001; 1: 713-9.
11. Yardeni IZ, Beilin B, Mayburd E, Alcalay Y, Bessler H. Relationship between fentanyl dosage and immune function in the postoperative period. J Opioid Manag 2008; 4: 27-33.
12. Farooqui M, Li Y, Rogers T, Poonawala T, Griffin RJ, Song CW, et al. COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumor growth, metastasis, and mortality, without compromising analgesia. Br J Cancer 2007; 97: 1523-31.
13. Echevarria G, Elgueta F, Fierro C, Bugedo D, Faba G, Iniguez-Cuadra R, et al. Nitrous oxide (N2O) reduces postoperative opioid-induced hyperalgesia after remifentanil-propofol anesthesia in humans. Br J Anaesth 2011; 107: 959-65.
14. Shin SW, Cho AR, Lee HJ, Kim HJ, Byeon GJ, Yoon JW, et al. Maintenance anaesthetics during remifentanil-based anaesthesia might affect postoperative pain control after breast cancer surgery. Br J Anaesth 2010; 105: 661-7.
15. Cronin-Fenton DP, Heide-Jorgensen U, Ahern TP, Lash TL, Christiansen PM, Ejlertsen B, et al. Opioids and breast cancer recurrence: a Danish population-based cohort study. Cancer 2015; 121: 3507-14.
16. Cata JP, Keerty M, Keerty D, Feng L, Norman PH, Gottumukkala V, et al. A retrospective analysis of the effect of intraoperative opioid dose on cancer recurrence after non-small cell lung cancer resection. Cancer Med 2014; 3: 900-8
17. Leahy KM, Ornverg RL, Wang Y, Zweifel BS, Koki AT, Masferrer JL. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. Cancer Res 2002; 62: 625-31.
18. Forget P, Vandenhende J, Berliere M, Machiels JP, Nussbaum B, Legrand C, et al. Do intraoperative analgesics influence breast cancer recurrence after mastectomy? A retrospective analysis. Anesth Analg 2010; 110: 1630-5.
19. Fleischmann E, Marschalek C, Schlemitz K, Dalton JE, Gruenberger T, Herbst F, et al. Nitrous oxide may not increase the risk of cancer recurrence after colorectal surgery: a follow-up of a randomized controlled trial. BMC Anesthesiol 2009; 9: 1.
20. Benzonana LL, Perry NJ, Watts HR, Yang B, Perry IA, Coombes C, et al. Isoflurane, a commonly used volatile anesthetic causes renal cancer growth and malignant potential via the hypoxia-inducible factor cellular signaling pathway in vitro. Anesthesiology 2013; 119: 593-605.
21. Markovic SN, Knight PR, Murasko DM. Inhibition of interferon stimulation of natural killer cell activity in mice anesthetized with halothane or isoflurane. Anesthesiology 1993; 78: 700-6.
22. Zhang T, Fan Y, Liu K, Wang Y. Effects of different general anesthetic techniques on immune responses in patients undergoing surgery for tongue cancer. Anaesth Intensive Care 2014; 42: 220-7.
23. Ren XF, Li WZ, Meng FY, Lin CF. Differential effects of propofol and isoflurane on the activation of T-helper cells in lung cancer patients. Anaestheisa 2010; 65: 478-82.
24. Deegan CA, Murray D, Doran P, Ecimovic P, Moriarty DC, Buggy DJ. Effect of anesthetic technique on oestrogen receptor-negative breast cancer cell function in vitro. Br J Anaesth 2009; 103: 685-90.
25. Exadaktylos AK, Buggy DJ, Moriarty DC, Mascha E, Sessler DI. Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology 2006; 105: 660-4.
26. Inada T, Kubo K, Shingu K. Possible link between cyclooxygenase-inhibiting and antitumor properties of propofol. J Anesth 2011; 25: 569-75.
27. Elmets CA, Viner JL, Pentland AP, Cantrell W, Lin HY, Bailey H, et al. Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blinded, placebo-controlled trial. J Natl Cancer Inst 2010; 102: 1835-44.
28. Inada T, Kubo K, Shingu K. Promotion of interferon-gamma production by natural killer cells via suppression of murine peritoneal macrophage prostaglandin E2 production using intravenous anesthetic propofol. Int Immunopharmacol 2010; 10: 1200-8.
29. Ke JJ, Zhan J, Feng XB, Wu Y, Rao Y, Wang YL. A comparison of the effect of total intravenous anesthesia with propofol and remifentanil and inhalational anesthesia with isoflurane on the release of pro-and anti-inflammatory cytokines in patients undergoing open cholecystectomy. Anaesth Intensive Care 2008; 36: 74-8.
30. Kurshumliu F, Gashi-Luci L, Kadare S, Alimehmeti M, Gozalan U. Classification of patients with breast cancer according to Nottingham Prognostic Index highlights significant differences in immunohistochemical marker expression. World J Surg Oncol 2014; 12: 243.